ロード中...
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
Dipeptidyl peptidase-4 (DPP-4) inhibitors have recently emerged as a new class of antidiabetic that show favorable results in improving glycemic control with a minimal risk of hypoglycemia and weight gain. Teneligliptin, a novel DPP-4 inhibitor, exhibits a unique structure characterized by five cons...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3650886/ https://ncbi.nlm.nih.gov/pubmed/23671395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S35682 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|